Emerging applications of natural language processing for the identification of steatotic liver disease [0.03%]
自然语言处理在肝脂肪病变识别中的新兴应用
Beverly Kyalwazi,Jeremy Louissaint
Beverly Kyalwazi
Generative AI in hepatology: Transforming multimodal patient-generated data into actionable insights [0.03%]
肝病学中的生成式AI：将多模态患者数据转化为行动见解
Mason Lai,Irene Y Chen,Jennifer C Lai et al.
Mason Lai et al.
Cirrhosis care is inherently complex, marked by a high risk of acute decompensation and significant morbidity and mortality. Traditional episodic care models provide static snapshots of a patient's condition, limiting the ability to address...
Diabetes mellitus in alcohol-associated liver disease: Prevalence and outcomes [0.03%]
糖尿病与酒精相关性肝病的流行率及临床预后研究
Ben Ward,Mark Theodoreson,Guruprasad Aithal et al.
Ben Ward et al.
Background: Alcohol associated liver disease (ALD) is a common condition that is a significant global cause of morbidity and mortality. Diabetes mellitus (DM) increases the risk of adverse outcomes in other types of steat...
Multicenter Study
Hepatology communications. 2025 Jul 14;9(8):e0734. DOI:10.1097/HC9.0000000000000734 2025
Tides of emotion: Hepatologists' role in navigating depression and anxiety in liver disease [0.03%]
肝病患者的抑郁和焦虑：肝病学家的作用不容忽视
Sarah Khan,Vinay Jahagirdar,Elliot B Tapper
Sarah Khan
Accuracy of the "Surprise Question" in predicting 90-day mortality among hospitalized patients with decompensated cirrhosis [0.03%]
" Surprise question" 在预测失代偿期肝硬化住院患者90天死亡率中的准确度
Margaret Selesky,Lucinda Li,Chengbo Zeng et al.
Margaret Selesky et al.
The impact of BCLC recommendations on survival for patients with hepatocellular carcinoma [0.03%]
BCLC指南对肝细胞癌患者生存影响的评估
Massimo Iavarone,Eleonora Alimenti,Lorenzo Canova et al.
Massimo Iavarone et al.
Background: The Barcelona Clinic Liver Cancer (BCLC) system for HCC was updated in 2022. The aim of the study was to assess the suitability and impact on overall survival (OS) of BCLC_2022, along with "clinical decision-m...
SLC1A5-dependent glutamine uptake in hepatocytes promotes liver regeneration [0.03%]
肝细胞中依赖于SLC1A5的谷氨酰胺摄取可促进肝再生
Yunhao Duan,Sheng Peng,Jinnan Yue et al.
Yunhao Duan et al.
Background: The liver's remarkable regenerative capacity after injury restores essential functions for maintaining homeostasis. Understanding molecular circuits initiating liver regeneration leads to new therapies. Solute...
ORP2 regulates free cholesterol accumulation in hepatocytes during MASH [0.03%]
ORP2调节MASH期间肝细胞中游离胆固醇的积累
Jin Wu,Yudi Zhao,Liwen Qiu et al.
Jin Wu et al.
Background: Cholesterol crystals in hepatocytes are known to strongly associate with human metabolic dysfunction-associated steatohepatitis. However, it remains unclear which molecular pathway(s) regulates free cholestero...
METTL3 inhibits liver fibrosis via RBX1 stability and TXNIP-mediated ferroptosis [0.03%]
METTL3通过RBX1稳定性和TXNIP介导的铁死亡抑制肝纤维化
Xin Liao,Likun Liu,Jinhui Du et al.
Xin Liao et al.
Background: Clinical treatment of liver fibrosis remains a significant challenge, necessitating the identification of molecules and factors capable of preventing or slowing its progression to develop more effective therap...
Zhiyu Li,Jianwen Situ,Shusheng Wu et al.
Zhiyu Li et al.
Background: HEV is an important cause of morbidity in solid organ transplant (SOT) recipients. However, the total burden of hepatitis E, including subclinical infections in this group, is not well defined. We compared hep...